UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
35 hedge funds and large institutions have $987K invested in Unity Biotechnology in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
91% less capital invested
Capital invested by funds: $11.4M → $987K (-$10.4M)
Holders
35
Holding in Top 10
2
Calls
$31K
Puts
$5K
Top Buyers
| 1 | +$110K | |
| 2 | +$29.7K | |
| 3 | +$14.7K | |
| 4 |
Renaissance Technologies
New York
|
+$3.51K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.41K |
Top Sellers
| 1 | -$8.46M | |
| 2 | -$304K | |
| 3 | -$42.9K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$24K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$21.4K |